BIOSPAIN 2026

The Decisions Behind Long-Term Success

Twenty years ago, 3PBIOVIAN was founded with a clear purpose: to advance global health by helping innovators bring new therapies to patients. Today, the company is a GMP manufacturing partner supporting healthcare innovators around the world.
What happened in between was neither luck nor a straight path to success. It was the result of deliberate decisions made over two decades of growth, transformation, and execution.
This roundtable explores the critical choices that enable biotechnology companies to move from scientific promise to industrial reality. Bringing together perspectives from an industry leader, a trusted customer, a quality and regulatory expert, and a growth investor, the discussion will examine the decisions that shaped the journey from startup ambition to international scale.
The conversation will explore the thinking behind those choices: setting a long-term strategic direction, building enduring customer partnerships, establishing a quality culture capable of meeting the highest regulatory standards, and securing the financial foundations required for sustainable growth.
This is a conversation about growth, resilience, and the decisions that turn ambition into lasting impact.